The development of a study protocol, and ethics and regulatory approval documentation, for evaluation of clinical efficacy of Sutherlandia frutescens in adult type-2 diabetics
dc.contributor.advisor | Syce, James A. | |
dc.contributor.author | Swead, Ramadan | |
dc.date.accessioned | 2018-04-11T11:07:02Z | |
dc.date.accessioned | 2024-10-29T14:20:14Z | |
dc.date.available | 2018-04-30T22:10:07Z | |
dc.date.available | 2024-10-29T14:20:14Z | |
dc.date.issued | 2018 | |
dc.description | Magister Scientiae - MSc (Pharmacy Administration and Policy Regulation) | |
dc.description.abstract | The prevalence of diabetes mellitus is increasing worldwide and it is becoming a significant medical problem in low- and middle-income countries. The condition can be controlled with a lifelong commitment to blood sugar monitoring, weight management, proper nutrition, exercise, and pharmacotherapy. Additional new pharmacotherapies are however needed to combat the increased prevalence and various traditionally used herbs, such as Sutherlandia frutescens (S, frutescens), are being advocated to supplement the management of type 2 diabetes mellitus. However, the clinical efficacy of S. frutescens in the management of type 2 diabetes mellitus has not yet been scientifically established. | |
dc.identifier.uri | https://hdl.handle.net/10566/16393 | |
dc.language.iso | en | |
dc.publisher | University of the Western Cape | |
dc.rights.holder | University of the Western Cape | |
dc.title | The development of a study protocol, and ethics and regulatory approval documentation, for evaluation of clinical efficacy of Sutherlandia frutescens in adult type-2 diabetics |
Files
Original bundle
1 - 1 of 1